Olfactory Impairment in Parkinson’s Disease and White Matter Abnormalities in Central Olfactory Areas
Objective: To determine white matter abnormalities in PD patients with various degrees of olfactory impairment. Background: Neuroimaging results of PD brain based on diffusion tensor…The influence of LRRK2 mutations on cholinergic system in manifest and prodromal stage of Parkinson’s disease: a positron emission tomography study
Objective: To evaluate the effects of leucine-rich repeat kinase 2 (LRRK2) mutations on the central cholinergic system in both manifesting and non-manifesting carriers using PET…Functional MAOB gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson’s disease
Objective: To examine the effects of common functional polymorphisms in genes involved in dopamine metabolism on striatal dopamine turnover estimated as the inverse of the…Substantia nigra area evaluated by neuromelanin-sensitive MRI as an imaging biomarker of disease progression in Parkinson’s disease
Objective: to investigate the pattern of substantia nigra - neuromelanin (SN-NM) area loss and contrast ratio (CR) intensity changes in late-stage Parkinson’s disease (LSPD) patients,…Alterations in Dynamic Brain Connectivity Patterns in Parkinson’s Disease
Objective: To explore the time varying brain connectivity networks in Parkinson's disease (PD) during resting-state fMRI and to investigate the correlate between connectivity dynamics and…Hippocampal iron deposition in Parkinson disease and Parkinson disease with dementia/Lewy body dementia: quantitative susceptibility mapping assessments
Objective: We compared quantitative susceptibility mapping (QSM) values in the hippocampi among patients with Parkinson disease (PD) and PD with dementia (PDD)/ Lewy body dementia…The prevalence of cerebral microbleeds in patients with Parkinson’s disease and multiple system atrophy
Objective: Here, we compared the prevalence of cerebral microbleeds (CMBs) in patients with parkinsonian disorders, including Parkinson’s diseaseParkinson’s disease (PD) and multiple system atrophy (MSA).…Parkinson’s disease with visual hallucination: optic radiation abnormalities on phase difference-enhanced imaging (PADRE)
Objective: We assessed structural abnormalities of optic radiation (OR) in patients with Parkinson disease (PD) with dementia (PDD) and dementia with lewy bodies (DLB) by…Hypertension and Parkinson’s disease
Objective: To compared clinical burden, neuropsychological features, CSF and imaging pathology in early untreated PD patients with and without HT. Background: Hypertension (HT) has been…The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease
Objective: We aimed to assess the association between phosphodiesterase 4 (PDE4) expression and sleep disturbances in vivo using combined multimodal magnetic resonance imaging (MRI) and…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.